Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Malignancy”

675 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 675 results

Not applicableStudy completedNCT01776372
What this trial is testing

Comparison of Pleural Drainage Systems on Reducing Pleural Effusion Formation Following Lung Resection

Who this might be right for
Lung NeoplasmsPleural Effusion
McMaster University 103
Large-scale testing (Phase 3)Study completedNCT00002872
What this trial is testing

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

Who this might be right for
Metastatic Cancer
Eastern Cooperative Oncology Group 480
Large-scale testing (Phase 3)Study completedNCT00128102
What this trial is testing

Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)

Who this might be right for
MesotheliomaLung Cancer
Merck Sharp & Dohme LLC 661
Not applicableStudy completedNCT06436807
What this trial is testing

PMCF Study of the CE-marked Drainova® ArgentiC Catheter

Who this might be right for
Pleural EffusionPleural Effusion, MalignantAscites+1 more
ewimed GmbH 169
Early research (Phase 1)Ended earlyNCT01143545
What this trial is testing

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Who this might be right for
Lung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more
National Cancer Institute (NCI) 10
Not applicableNot Yet RecruitingNCT07167992
What this trial is testing

Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis

Who this might be right for
Pneumothorax Spontaneous PrimaryPneumothorax Spontaneous SecondaryPleural Effusion, Malignant+1 more
University of Health Sciences Lahore 160
Testing effectiveness (Phase 2)Ended earlyNCT01337154
What this trial is testing

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionStage IV Non-small Cell Lung Cancer
CytRx 140
Not applicableStudy completedNCT02625675
What this trial is testing

Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study

Who this might be right for
Malignant Pleural Effusion
University of Oxford 18
Not applicableStudy completedNCT04324437
What this trial is testing

ERAPID: Online Symptom Reporting in Lung Cancer

Who this might be right for
Thoracic CancerNon-small Cell Lung CancerSmall-cell Lung Cancer+1 more
University of Leeds 43
Not applicableLooking for participantsNCT06959719
What this trial is testing

ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG

Who this might be right for
Non-expandable LungTrapped LungPleural Effusion+1 more
Cambridge University Hospitals NHS Foundation Trust 41
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Testing effectiveness (Phase 2)Study completedNCT03394105
What this trial is testing

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

Who this might be right for
Pleural Effusion, MalignantNon-small Cell Carcinoma
Asan Medical Center 4
Not applicableStudy completedNCT07065422
What this trial is testing

AI Models for Predicting Occult Pleural Dissemination in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 326
Testing effectiveness (Phase 2)Looking for participantsNCT07332858
What this trial is testing

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusions (Mpe)Non Small Cell Lung Cancer
Gang Hou 105
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Ended earlyNCT02250118
What this trial is testing

Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer

Who this might be right for
Pleural Effusion, MalignantBreast Cancer
Institut Curie 1
Not applicableUnknownNCT06512896
What this trial is testing

Clinical Study on Intraluminal Injection of FOLactis

Who this might be right for
Solid TumorImmune ResponsePleural Effusion, Malignant+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)UnknownNCT05330065
What this trial is testing

Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusion
The First Affiliated Hospital of Zhengzhou University 55
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Next Page